AstraZeneca
AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three main therapy areas – Respiratory and Autoimmunity, Cardiovascular and Metabolic Diseases, and Oncology.
See below for the Latest AstraZeneca News, Analysis, Profit Results, Share Price Information, and Commentary.
AstraZeneca HK, Lippo Healthcare partner for health innovation in GBA
AstraZeneca HK, Lippo Healthcare partner for health innovation in GBA
The collaboration will address healthcare challenges in treating chronic diseases.
Join the community
Most Read
1. Singapore consumers show rising openness to agentic AI shopping 2. DANA Indonesia launches verified digital wallet for teens 3. India insurance market sees moderating premium growth: Report 4. Singapore’s non-life insurers see growth as offshore business expands 5. PLN expands gas, LNG network to support rising renewablesResource Center
Awards
Event News
Co-Written / Partner
Boost Group CEO, Sheyantha Abeykoon hailed Executive of the Year - Financial Technology at Malaysia Management Excellence Awards 2025
His ability to combine vision with humility, growth, and responsibility made him stand out.
Commentary
Fees friction is testing Asia’s academic ambitions
Turning the tide on friendly fraud as Asia’s payments surge